EBAY
43
3
CHRW
53
3
GIS
29
3
GE
61
4
ADI
45
-2
AVY
53
3
NKE
30
2
CTAS
53
3
AMP
66
3
ADBE
43
3
PYPL
41
2
AMAT
46
6
GME
57
2
HIG
54
2
DUK
37
2
KEY
34
3
BF.B
31
2
EQT
30
5
BEN
34
6
PX
66
4
EBAY
43
3
CHRW
53
3
GIS
29
3
GE
61
4
ADI
45
-2
AVY
53
3
NKE
30
2
CTAS
53
3
AMP
66
3
ADBE
43
3
PYPL
41
2
AMAT
46
6
GME
57
2
HIG
54
2
DUK
37
2
KEY
34
3
BF.B
31
2
EQT
30
5
BEN
34
6
PX
66
4
Financhill
Back

Protalix BioTherapeutics Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
70

PLX
Protalix BioTherapeutics

Last Price:
1.29
Seasonality Move:
64.55%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Protalix BioTherapeutics Price Quote

$1.29
-0.01 (0.78%)
(Updated: November 6, 2024 at 5:22 AM ET)

Protalix BioTherapeutics Key Stats

Buy
70
Protalix BioTherapeutics (PLX) is a Buy
Day range:
$1.27 - $1.32
52-week range:
$0.82 - $1.90
Dividend yield:
0%
P/E ratio:
14.44
P/S ratio:
2.70
P/B ratio:
3.35%
Volume:
159K
Avg. volume:
169.8K
1-year change:
-29.73%
Market cap:
$95.6M
Revenue:
$65.5M
EPS:
$-0.23

How Much Does Protalix BioTherapeutics Make?

Is Protalix BioTherapeutics Growing As A Company?

Protalix BioTherapeutics Stock Price Performance

What Is Protalix BioTherapeutics 52-Week High & Low?

Protalix BioTherapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Protalix BioTherapeutics?

Is Protalix BioTherapeutics Cash Flow Positive?

  • What Is PLX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$2.7M
  • What Is Protalix BioTherapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Protalix BioTherapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$22M

Protalix BioTherapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    PLX return on invested capital is -27.15%
  • What Is Protalix BioTherapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -16.63%
  • What Is PLX Return On Equity?
    ROE is a measure of profitability and is -43.43%

Protalix BioTherapeutics Earnings Date & Stock Price

Protalix BioTherapeutics Competitors

Protalix BioTherapeutics Dividend Yield

Protalix BioTherapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -61.59% -60.03%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.00
Upside from Last Price: 976.92%

Major Shareholders

  • How many PLX shares are owned by institutional investors?
    6.9M PLX shares are owned by institutional investors
  • How many PLX shares are owned by insiders?
    4.7M PLX shares are owned by insiders